600285 羚銳製藥
按盤價 
24.260 -0.320 (-1.302%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 909,047 | 15.27% | 3,311,473 | 3,001,862 | 2,693,511 | 2,331,577 | |
| 減：營業總成本 | 696,498 | 11.84% | 2,683,304 | 2,584,417 | 2,296,634 | 1,997,801 | |
| 其中:營業成本 | 221,832 | 19.87% | 884,387 | 832,114 | 692,993 | 538,403 | |
| 財務費用 | (8,021) | 37.83% | (35,120) | (26,588) | (10,334) | (15,290) | |
| 資產減值損失 | (4) | -88.31% | (2,873) | (171) | (8,775) | (32,028) | |
| 公允價值變動收益 | 733 | 1,642.96% | 121 | 5,926 | 46 | (52) | |
| 投資收益 | 6,856 | 65.39% | 20,154 | 58,655 | 30,555 | 41,208 | |
| 其中：對聯營企業和合營企業的投資收益 | (4) | -110.35% | (385) | 43,350 | 18,522 | 33,230 | |
| 營業利潤 | 220,826 | 29.42% | 656,307 | 517,121 | 435,012 | 367,092 | |
| 利潤總額 | 220,820 | 29.93% | 653,044 | 517,035 | 413,351 | 364,201 | |
| 減：所得稅費用 | 30,492 | 18.31% | 84,928 | 51,730 | 50,852 | 39,819 | |
| 淨利潤 | 190,329 | 32.01% | 568,116 | 465,305 | 362,500 | 324,382 | |
| 減：非控股權益 | (50) | -24.33% | 6 | 0 | 957 | (1,107) | |
| 股東淨利潤 | 190,379 | 31.98% | 568,109 | 465,305 | 361,543 | 325,489 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.340 | 30.77% | 1.012 | 0.836 | 0.650 | 0.573 | |
| 每股派息 (元) * | -- | -- | 0.800 | 0.600 | 0.500 | 0.400 | |
| 每股淨資產 (元) * | 5.173 | 8.77% | 4.921 | 4.495 | 4.014 | 4.073 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 08/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
